Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market
Description
Asia-Pacific blood plasma & plasma derived medicinal products market is expected to reach USD 11.61 billion by 2032 from USD 5.96 billion in 2024, growing at a CAGR of 8.73% during the forecast period of 2025 to 2032.
Market Segmentation:
Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Product (Immunoglobulins, Coagulation Factors (For Bleeding Disorders), Albumin (Plasma Volume Expander), Protease Inhibitors (For Genetic Deficiencies), Monoclonal Antibodies (Derived From Plasma Cells), and Other Plasma Derived Proteins), Application (Immunology, Hematology, Critical Care, Neurology, Pulmonology, Haemato-Oncology, Rheumatology, and Other Applications), Processing Technology (Ion Exchange Chromatography, Affinity Chromatography, Cryoprecipitation, Ultrafiltration, and Microfiltration), Mode (Modern and Traditional Plasma Fractionation), End-User (Hospitals & Clinics, Research Labs, Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (China, Japan, South Korea, Australia, India, Malaysia, Thailand, Singapore, Philippines, Indonesia, New Zealand, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2032
Overview of the Asia-Pacific Blood Plasma & Plasma Derived Medicinal Market Dynamics:
Drivers
• Rising prevalence of rare and chronic diseases
• Expanding geriatric population
Restraints
• High cost and complex manufacturing process
• Lack of plasma supply and donor
Opportunities
• Advancements in plasma processing technologies to enhance yield and reduce costs
• Reimbursement frameworks and increased governmental focus on rare disease treatment
Market Players:
The key players operating in the Asia-Pacific blood plasma & plasma derived medicinal products market are:
• CSL
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Octapharma AG
• Kedrion
• Aegros
• Bharat Serums
• Biotest AG
• Fresenius Kabi AG
• GC Biopharma corporate
• ICHOR
• Intas Pharmaceuticals Ltd.
• Kamada Pharmaceuticals
• KM Biologics
• PlasmaGen BioSciences Pvt. Ltd.
• Proliant Health & Biologicals
• Promea
• Reliance Life Sciences
• Sichuan Yuanda Shyuang Pharmaceutical Co., Ltd.
• SK Plasma
• Synthaverse S. A.
• Taibang Bio Group Co., Ltd
• VIRCHOW BIOTECH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Market Segmentation:
Asia-Pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Product (Immunoglobulins, Coagulation Factors (For Bleeding Disorders), Albumin (Plasma Volume Expander), Protease Inhibitors (For Genetic Deficiencies), Monoclonal Antibodies (Derived From Plasma Cells), and Other Plasma Derived Proteins), Application (Immunology, Hematology, Critical Care, Neurology, Pulmonology, Haemato-Oncology, Rheumatology, and Other Applications), Processing Technology (Ion Exchange Chromatography, Affinity Chromatography, Cryoprecipitation, Ultrafiltration, and Microfiltration), Mode (Modern and Traditional Plasma Fractionation), End-User (Hospitals & Clinics, Research Labs, Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (China, Japan, South Korea, Australia, India, Malaysia, Thailand, Singapore, Philippines, Indonesia, New Zealand, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2032
Overview of the Asia-Pacific Blood Plasma & Plasma Derived Medicinal Market Dynamics:
Drivers
• Rising prevalence of rare and chronic diseases
• Expanding geriatric population
Restraints
• High cost and complex manufacturing process
• Lack of plasma supply and donor
Opportunities
• Advancements in plasma processing technologies to enhance yield and reduce costs
• Reimbursement frameworks and increased governmental focus on rare disease treatment
Market Players:
The key players operating in the Asia-Pacific blood plasma & plasma derived medicinal products market are:
• CSL
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Octapharma AG
• Kedrion
• Aegros
• Bharat Serums
• Biotest AG
• Fresenius Kabi AG
• GC Biopharma corporate
• ICHOR
• Intas Pharmaceuticals Ltd.
• Kamada Pharmaceuticals
• KM Biologics
• PlasmaGen BioSciences Pvt. Ltd.
• Proliant Health & Biologicals
• Promea
• Reliance Life Sciences
• Sichuan Yuanda Shyuang Pharmaceutical Co., Ltd.
• SK Plasma
• Synthaverse S. A.
• Taibang Bio Group Co., Ltd
• VIRCHOW BIOTECH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
350 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestle Analysis
- 4.1.1 Political Factors
- 4.1.2 Economic Factors
- 4.1.3 Social Factors
- 4.1.4 Technological Factors
- 4.1.5 Environmental Factors
- 4.1.6 Legal Factors
- 4.2 Porter’s Five Forces
- 4.2.1 Threat Of New Entrants
- 4.2.2 Bargaining Power Of Suppliers
- 4.2.3 Bargaining Power Of Buyers
- 4.2.4 Threat Of Substitutes
- 4.2.5 Industry Rivalry
- 4.3 Supply Chain Impact On The Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market
- 4.3.1 Overview
- 4.3.2 Raw Material Availability
- 4.3.3 Manufacturing Capacity
- 4.3.4 Logistics And Last-mile Hurdles
- 4.3.5 Pricing Models And Market Positioning
- 4.4 Innovation Strategies
- 4.4.1 Key Innovation Strategies
- 4.4.2 Emerging Delivery Techniques
- 4.4.3 Strategic Implications
- 4.4.4 Conclusion
- 4.5 Risk And Mitigation
- 4.6 Vendor Selection Dynamics
- 4.6.1 Product Quality And Regulatory Compliance
- 4.6.2 Supply Chain Capabilities And Reliability
- 4.6.3 Clinical Efficacy And Innovation
- 4.6.4 Cost Competitiveness And Reimbursement Compatibility
- 4.6.5 Local Market Presence And Support Infrastructure
- 4.6.6 Ethical Sourcing, Esg Compliance, And Transparency
- 4.6.7 Conclusion
- 4.7 Tariffs And Their Impact On Market
- 4.7.1 Current Tariff Rates In Top-5 Country Markets
- 4.7.2 Outlook: Local Production V/S Import Reliance
- 4.7.3 Vendor Selection Criteria Dynamics
- 4.7.4 Impact On Supply Chain
- 4.7.5 Impact On Prices
- 4.7.6 Regulatory Inclination
- 4.7.6.1 Gcc Trade Alignment & Ftas
- 4.7.6.2 Special Zones And Re-export Models
- 4.7.6.3 Local Subsidy & Policy Response
- 4.7.6.4 Domestic Course Of Correction
- 5 Regulation Coverage
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Rising Prevalence Of Rare And Chronic Diseases
- 6.1.2 Expanding Geriatric Population
- 6.1.3 Technological Advancements In Plasma Fractionation
- 6.1.4 Government And Institutional Support
- 6.2 Restraints
- 6.2.1 High Cost And Complex Manufacturing Process
- 6.2.2 Lack Of Plasma Supply And Donor
- 6.3 Opportunities
- 6.3.1 Advancements In Plasma Processing Technologies To Enhance Yield And Reduce Costs
- 6.3.2 Reimbursement Frameworks And Increased Governmental Focus On Rare Disease Treatment
- 6.3.3 Strategic Alliances, Mergers, And Acquisitions To Strengthen Asia-pacific Market Penetration
- 6.4 Challenges
- 6.4.1 Competitive Pressure From Recombinant And Alternative Biological Therapies
- 6.4.2 Infrastructure Limitations In Cold Chain Logistics Impacting Product Distribution
- 7 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Product
- 7.1 Overview
- 7.2 Immunoglobulins
- 7.3 Coagulation Factors (For Bleeding Disorders)
- 7.4 Albumin (Plasma Volume Expander)
- 7.5 Protease Inhibitors (For Genetic Deficiencies)
- 7.6 Monoclonal Antibodies (Derived From Plasma Cells)
- 7.7 Other Plasma Derived Proteins
- 8 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Application
- 8.1 Overview
- 8.2 Immunology
- 8.3 Hematology
- 8.4 Critical Care
- 8.5 Neurology
- 8.6 Pulmonology
- 8.7 Haemato-oncology
- 8.8 Rheumatology
- 8.9 Other Applications
- 9 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Technology
- 9.1 Overview
- 9.2 Ion Exchange Chromatography
- 9.3 Affinity Chromatography
- 9.4 Cryoprecipitation
- 9.5 Ultrafiltration
- 9.6 Microfiltration
- 10 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Mode
- 10.1 Overview
- 10.2 Modern
- 10.3 Traditional Plasma Fractionation
- 11 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By End User
- 11.1 Overview
- 11.2 Hospitals & Clinics
- 11.3 Research Labs
- 11.4 Academic Institutes
- 11.5 Others
- 12 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel
- 12.1 Overview
- 12.2 Direct Tenders
- 12.3 Third Party Distributors
- 12.4 Others
- 13 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Region
- 13.1 Asia-pacific
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 South Korea
- 13.1.4 Australia
- 13.1.5 India
- 13.1.6 Malaysia
- 13.1.7 Thailand
- 13.1.8 Singapore
- 13.1.9 Philippines
- 13.1.10 Indonesia
- 13.1.11 New Zealand
- 13.1.12 Vietnam
- 13.1.13 Taiwan
- 13.1.14 Rest Of Asia-pacific
- 14 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, Company Landscape
- 14.1 Company Share Analysis: Asia-pacific
- 15 Swot Analysis
- 16 Company Profile
- 16.1 Csl
- 16.1.1 Company Snapshot
- 16.1.2 Revenue Analysis
- 16.1.3 Company Share Analysis
- 16.1.4 Product Portfolio
- 16.1.5 Recent Developments
- 16.2 Takeda Pharmaceutical Company Limited
- 16.2.1 Company Snapshot
- 16.2.2 Revenue Analysis
- 16.2.3 Company Share Analysis
- 16.2.4 Product Portfolio
- 16.2.5 Recent Developments
- 16.3 Grifols, S.A.
- 16.3.1 Company Snapshot
- 16.3.2 Revenue Analysis
- 16.3.3 Company Share Analysis
- 16.3.4 Product Portfolio
- 16.3.5 Recent Developments
- 16.4 Octapharma Ag
- 16.4.1 Company Snapshot
- 16.4.2 Company Share Analysis
- 16.4.3 Product Portfolio
- 16.4.4 Recent Developments
- 16.5 Kedrion
- 16.5.1 Company Snapshot
- 16.5.2 Company Share Analysis
- 16.5.3 Product Portfolio
- 16.5.4 Recent Development
- 16.6 Adma Biologics, Inc
- 16.6.1 Company Snapshot
- 16.6.2 Revenue Analysis
- 16.6.3 Product Portfolio
- 16.6.4 Recent Development
- 16.7 Aegros
- 16.7.1 Company Snapshot
- 16.7.2 Product Portfolio
- 16.7.3 Recent Development
- 16.8 Bharat Serums
- 16.8.1 Company Snapshot
- 16.8.2 Product Portfolio
- 16.8.3 Recent Development
- 16.9 Biotest Ag.
- 16.9.1 Company Snapshot
- 16.9.2 Revenue Analysis
- 16.9.3 Product Portfolio
- 16.9.4 Recent Developments
- 16.10 Fresenius Kabi Ag
- 16.10.1 Company Snapshot
- 16.10.2 Product Portfolio
- 16.10.3 Recent Development
- 16.11 Gc Biopharma Corporate
- 16.11.1 Company Snapshot
- 16.11.2 Revenue Analysis
- 16.11.3 Product Portfolio
- 16.11.4 Recent Development
- 16.12 Ichor
- 16.12.1 Company Snapshot
- 16.12.2 Product Portfolio
- 16.12.3 Recent Development
- 16.13 Intas Pharmaceuticals Ltd.
- 16.13.1 Company Snapshot
- 16.13.2 Product Portfolio
- 16.13.3 Recent Development
- 16.14 Kamada Pharmaceuticals
- 16.14.1 Company Snapshot
- 16.14.2 Revenue Analysis
- 16.14.3 Product Portfolio
- 16.14.4 Recent Development
- 16.15 Km Biologics
- 16.15.1 Company Snapshot
- 16.15.2 Product Portfolio
- 16.15.3 Recent Development
- 16.16 Lfb
- 16.16.1 Company Snapshot
- 16.16.2 Product Portfolio
- 16.16.3 Recent Development
- 16.17 Plasmagen Biosciences Pvt. Ltd.
- 16.17.1 Company Snapshot
- 16.17.2 Product Portfolio
- 16.17.3 Recent Developments
- 16.18 Proliant Health & Biologicals
- 16.18.1 Company Snapshot
- 16.18.2 Product Portfolio
- 16.18.3 Recent Development
- 16.19 Promea
- 16.19.1 Company Snapshot
- 16.19.2 Product Portfolio
- 16.19.3 Recent Development
- 16.20 Reliance Life Sciences
- 16.20.1 Company Snapshot
- 16.20.2 Business Portfolio
- 16.20.3 Recent Development
- 16.21 Sichuan Yuanda Shyuang Pharmaceutical Co., Ltd.
- 16.21.1 Company Snapshot
- 16.21.2 Product Portfolio
- 16.21.3 Recent Development
- 16.22 Sk Plasma
- 16.22.1 Company Snapshot
- 16.22.2 Product Portfolio
- 16.22.3 Recent Development
- 16.23 Synthaverse S. A.
- 16.23.1 Company Snapshot
- 16.23.2 Revenue Analysis
- 16.23.3 Product Portfolio
- 16.23.4 Recent Developments
- 16.24 Taibang Bio Group Co., Ltd
- 16.24.1 Company Snapshot
- 16.24.2 Product Portfolio
- 16.24.3 Recent Development
- 16.25 Virchow Biotech
- 16.25.1 Company Snapshot
- 16.25.2 Product Portfolio
- 16.25.3 Recent Development
- 17 Questionnaire
- 18 Related Reports
- List Of Tables
- Table 1 Regulatory Framework And Guidelines
- Table 2 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 3 Asia-pacific Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 4 Asia-pacific Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 5 Asia-pacific Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 6 Asia-pacific Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 7 Asia-pacific Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 8 Asia-pacific Coagulation Factors In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 9 Asia-pacific Factor Ix In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 10 Asia-pacific Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 11 Asia-pacific Factor Viii In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 12 Asia-pacific Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 13 Asia-pacific Fibrinogen In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 14 Asia-pacific Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 15 Asia-pacific Von Willebrand Factor (Vwf) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 16 Asia-pacific Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 17 Asia-pacific Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 18 In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 19 Asia-pacific Albumin In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 20 Asia-pacific Protease Inhibitors (For Genetic Deficiencies)In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 21 Asia-pacific Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 22 Asia-pacific Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 23 Asia-pacific C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 24 Asia-pacific Monoclonal Antibodies (Derived From Plasma Cells )In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 25 Asia-pacific Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 26 Asia-pacific Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 27 Asia-pacific Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 28 Asia-pacific Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 29 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2025-2032 (Usd Thousand)
- Table 30 Asia-pacific Immunology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 31 Asia-pacific Hematology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 32 Asia-pacific Critical Care In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 33 Asia-pacific Neurology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 34 Asia-pacific Pulmonology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 35 Asia-pacific Hematology -oncology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 36 Asia-pacific Rheumatology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 37 Asia-pacific Other Applications In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 38 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Technology, 2025-2032 (Usd Thousand)
- Table 39 Asia-pacific Ion Exchange Chromatography In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 40 Asia-pacific Affinity Chromatography In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 41 Asia-pacific Cryoprecipitation In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 42 Asia-pacific Ultrafiltration In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 43 Asia-pacific Microfiltration In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 44 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2025-2032 (Usd Thousand)
- Table 45 Asia-pacific Modern In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 46 Asia-pacific Traditional Plasma Fractionation In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 47 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2025-2032 (Usd Thousand)
- Table 48 Asia-pacific Hospitals & Clinics In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 49 Asia-pacific Research Labs In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 50 Asia-pacific Academic Institutes In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 51 Asia-pacific Others Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 52 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2025-2032 (Usd Thousand)
- Table 53 Asia-pacific Direct Tenders In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 54 Asia-pacific Third Party Distributors In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 55 Asia-pacific Others In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 56 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Country, 2018-2032 (Usd Thousand)
- Table 57 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 58 Asia-pacific Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 59 Asia-pacific Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 60 Asia-pacific Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 61 Asia-pacific Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 62 Asia-pacific Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 63 Asia-pacific Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 64 Asia-pacific Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 65 Asia-pacific Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 66 Asia-pacific Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 67 Asia-pacific Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 68 Asia-pacific Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 69 Asia-pacific Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 70 Asia-pacific Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 71 Asia-pacific Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 72 Asia-pacific Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 73 Asia-pacific Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 74 Asia-pacific C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 75 Asia-pacific Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 76 Asia-pacific Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 77 Asia-pacific Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 78 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 79 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 80 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 81 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 82 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 83 China Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 84 China Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 85 China Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 86 China Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 87 China Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 88 China Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 89 China Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 90 China Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 91 China Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 92 China Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 93 China Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 94 China Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 95 China Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 96 China Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 97 China Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 98 China Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 99 China Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 100 China C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 101 China Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 102 China Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 103 China Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 104 China Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 105 China Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 106 China Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 107 China Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 108 China Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 109 Japan Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 110 Japan Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 111 Japan Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 112 Japan Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 113 Japan Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 114 Japan Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 115 Japan Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 116 Japan Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 117 Japan Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 118 Japan Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 119 Japan Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 120 Japan Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 121 Japan Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 122 Japan Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 123 Japan Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 124 Japan Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 125 Japan Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 126 Japan C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 127 Japan Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 128 Japan Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 129 Japan Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 130 Japan Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 131 Japan Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 132 Japan Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 133 Japan Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 134 Japan Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 135 South Korea Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 136 South Korea Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 137 South Korea Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 138 South Korea Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 139 South Korea Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 140 South Korea Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 141 South Korea Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 142 South Korea Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 143 South Korea Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 144 South Korea Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 145 South Korea Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 146 South Korea Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 147 South Korea Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 148 South Korea Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 149 South Korea Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- List Of Figures
- Figure 1 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Segmentation
- Figure 2 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Data Triangulation
- Figure 3 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Droc Analysis
- Figure 4 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Asia-pacific Vs Regional Market Analysis
- Figure 5 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Company Research Analysis
- Figure 6 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Multivariate Modelling
- Figure 7 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Interview Demographics
- Figure 8 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Dbmr Market Position Grid
- Figure 9 Asia-pacific Blood Plasma & Plasma Derived Medicinal Products Market: Market End User Coverage Grid
- Figure 10 Asia-pac
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
